Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
Surgery is the front-line therapy for non-small cell lung cancer (NSCLC) but postoperative
complications remains high and patients' long-term outcome is still challenging. In addition
to surgery, anesthetic management particularly intraoperative blood pressure management and
use of dexamethasone may affect patients' early and long-term outcomes after surgery for
NSCLC. This study aims to investigate the impact of intraoperative blood pressure management
and dexamethasone administration on early and long-term outcomes in patients undergoing
surgery for lung cancer.